<bill session="114" type="h" number="2325" updated="2015-07-25T06:38:25-04:00">
  <state datetime="2015-05-14">REFERRED</state>
  <status>
    <introduced datetime="2015-05-14"/>
  </status>
  <introduced datetime="2015-05-14"/>
  <titles>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to provide for a pharmaceutical and technology ombudsman under the Medicare program.</title>
  </titles>
  <sponsor id="412539"/>
  <cosponsors>
    <cosponsor id="412250" joined="2015-05-14"/>
  </cosponsors>
  <actions>
    <action datetime="2015-05-14" state="REFERRED">
      <text>Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2015-05-14">
      <text>Referred to House Ways and Means</text>
    </action>
    <action datetime="2015-05-14">
      <text>Referred to House Energy and Commerce</text>
    </action>
    <action datetime="2015-05-15">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee activity="Referral" code="HSIF14" subcommittee="Health" name="House Energy and Commerce"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Administrative remedies"/>
    <term name="Department of Health and Human Services"/>
    <term name="Executive agency funding and structure"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Manufacturing"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary>5/14/2015--Introduced.
This bill amends title XVIII (Medicare) of the Social Security Act to direct the Department of Health and Human Services to provide for a pharmaceutical and technology ombudsman within the Centers for Medicare and Medicaid Services.</summary>
</bill>
